Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) went up by 0.43% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Biotechnology giant went up by $11.58 to trade ended Wednesday trading at $11.53. This is up from the $11.53 price recorded on Tuesday’s trading session. Thanks to this latest performance, VNDA is closer to the higher price 52-week target of $25.00 and further from the lowest price target of $13.00. Its performance from the start of the year has also been negative, with VNDA down by -29.43% year-to-date.
Vanda Pharmaceuticals Inc. (VNDA) started the day trading at $11.56 and recorded an intraday high of $11.68. It also recorded an intraday low of $11.38 during Wednesday’s trading session. Vanda Pharmaceuticals Inc. is a very active stock that recorded a trading volume that is less than -120.11% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 323409, which is less than -120.11 of the total average daily trading volume of 711.85K.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) 2020 Performance Impressive
The increase in VNDA’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of VNDA currently stands at $17.85, which is higher than the current trading price of the stock by 35.13%. However, VNDA’s current trading price is -62.64% lower than the 52-week low price of $7.12. In terms of trading volume, Vanda Pharmaceuticals Inc. currently experienced healthy participation during the last trading session. 323409 shares of Vanda Pharmaceuticals Inc. were traded on the stock exchange on Wednesday, which is less than -120.11% of the 711.85K average trading volume of the stock.
The performance of the stock has been positive over the past year. VNDA’s performance over the past one year has seen it plunge by -15.16%, while the stock has gone down by -29.56% in the last six months. The quarterly performance of VNDA currently stands at 9.14%, and it is down by -0.52% in the last month. The only positive figure was from the weekly performance, which currently reads 1.22%. At the time of writing VNDA’s report, the company has a total market cap of $635.97M, making it one of the largest publicly-traded companies in the world.Vanda Pharmaceuticals Inc. also has over 284 employees all over the world.
VNDA Insider Activities
For Vanda Pharmaceuticals Inc., insiders hold 98.00% of all company shares. The insider transactions over the past six months are up by 8.30%. During that period, insiders bought 235,000 shares in 12 transactions. In that same period, insiders sold 77,836 of their shares in 11 transactions. After these transactions, insiders at Vanda Pharmaceuticals Inc. now hold 1.66M shares, which is over 98.00% of the total company stocks. Institutional investors currently hold a large chunk of the VNDA shares, as they control 3.04% of the company’s total stock.
VNDA Fundamental Analysis
For Vanda Pharmaceuticals Inc., the stock’s diluted earnings per share (EPS) stands at 2.14. In the coming year, analysts expect the EPS to be 0.02. The stock’s EPS growth this year is 343.30%, 30.80% in the previous five years. In terms of revenue, Vanda Pharmaceuticals Inc.’s quarterly sales (YOY) is growing at 0.04, which is lower than the average annual revenue of 30.80% over the past half a decade.
The Return on Investment (ROI) on Vanda Pharmaceuticals Inc.’s stock currently stands at 26.60%, and it has a net profit margin of 49.10%. The operating margin of the company is 10.40%, and its gross margin is 89.60%.
VNDA Analysts Prediction
Analysts at Stifel believe that VNDA is Hold, and they have a price target of between $26 and $17. Jefferies and Jefferies also believe that Vanda Pharmaceuticals Inc.’s stock is outperforming at the moment.
VNDA Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of VNDA currently stands at 1.83%, while the SMA50 is 1.25%. The biggest one is the SMA200, which is currently reading -10.61% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 51.89, while its price to earnings ratio (P/E) is 5.42.